familial hemophagocytic lymphohistiocytosis 4
|
MONDO_0011336 |
[Any genetic hemophagocytic lymphohistiocytosis in which the cause of the disease is a mutation in the STX11 gene.] |
anemia, nonspherocytic hemolytic, due to G6PD deficiency
|
MONDO_0010480 |
[An X-linked genetic condition caused by alterations in the gene G6PD that result in severely decreased activity levels of the enzyme glucose-6-phosphate dehydrogenase. Individuals with hemizygous G6PD variants associated with CNSHA have CNSHA. Individuals with G6PD variants that cause CNSHA are at risk for acute hemolytic anemia in response to certain medication exposures, chemical exposures, infections, or consumption of fava beans.] |
anemia, nonspherocytic hemolytic
|
MONDO_0000105 |
|
anemia due to erythrocyte enzyme disorder
|
MONDO_0020585 |
[Any form of anemia that results from the absence of, or the defective action of, any enzyme involved in erythropoiesis.] |
inborn disorder of pentose phosphate metabolism
|
MONDO_0019231 |
|
lymphedema
|
MONDO_0019297 |
[Excess fluid collection in tissues, causing swelling. It is the result of obstruction of lymphatic vessels or lymph nodes.] |
lymphatic system disorder
|
MONDO_0005833 |
[A disease involving the lymphatic part of lymphoid system.] |
angioedema
|
MONDO_0010481 |
[Swelling involving the deep dermis, subcutaneous, or submucosal tissues, representing localized edema. Angioedema often occurs in the face, lips, tongue, and larynx.] |
skin vascular disease
|
MONDO_0019293 |
[A disease that involves the superficial vasculature.] |
urticaria
|
MONDO_0005492 |
[A vascular reaction of the skin characterized by erythema and wheal formation due to localized increase of vascular permeability. The causative mechanism may be allergy, infection, or stress.] |
blood coagulation disease
|
MONDO_0001531 |
[A condition in which there is a deviation from or interruption of the normal coagulation properties of the blood.] |
inborn organic aciduria
|
MONDO_0000688 |
[An inherited disorder that affects the metabolism of any acidic compound containing carbon in a covalent linkage.] |
autosomal dominant titinopathy
|
MONDO_0100494 |
[Autosomal dominant form of TTN-related myopathy.] |
thrombocytopenia 6
|
MONDO_0014837 |
|
hereditary disorder of connective tissue
|
MONDO_0023603 |
[An inherited genetic disorder that affects the connective tissues. Representative examples include Ehlers-Danlos syndrome and Marfan syndrome.] |
myeloproliferative neoplasm
|
MONDO_0020076 |
[A clonal hematopoietic stem cell disorder, characterized by proliferation in the bone marrow of one or more of the myeloid (i.e., granulocytic, erythroid, megakaryocytic, and mast cell) lineages. It is primarily a neoplasm of adults. (WHO 2008)] |
UROD-related inherited porphyria
|
MONDO_0100498 |
[Any inherited porphyria in which the cause of the disease is monoallelic or biallelic variants in the UROD gene.] |
Charcot-Marie-Tooth disease axonal type 2CC
|
MONDO_0014836 |
[Any Charcot-Marie-Tooth disease in which the cause of the disease is a mutation in the NEFH gene.] |
headache disorder
|
MONDO_0021146 |
[Various conditions with the symptom of headache. Headache disorders are classified into major groups, such as primary headache disorders (based on characteristics of their headache symptoms) and secondary headache disorders (based on their etiologies). (International Classification of Headache Disorders, 2nd ed. Cephalalgia 2004: suppl 1)] |
neurological pain disorder
|
MONDO_0700057 |
[A nervous system disorder that has pain as a major feature.] |